MTOR and biliary tract cancer: Inhibition of mTOR signalling has demonstrated antitumour activity in individual biliary tract cancer cell lines (Moolthiya et al., 2014) and in a transgenic mouse model of biliary tract cancer (Wu et al., 2007).